
Cronos Group CRON
€ 2.20
-0.39%
Cronos Group Finanzkreislauf 2011-2026 | CRON
Finanzkreislauf Jährlich Cronos Group
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 213 | 278 | 605 | 592 | 1.52 K | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.52 K | 213 | 642 |
Finanzkreislauf anderer Aktien in der Arzneimittelhersteller
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agile Therapeutics
AGRX
|
-206 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
-38 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-224 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
460 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
110 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
41.4 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
-128 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
137 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
139 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
141 | - | - | $ 28.9 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
192 | - | - | $ 2.06 B | ||
|
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
-161 | $ 3.12 | 0.97 % | $ 43.9 M | ||
|
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
78.9 | $ 5.72 | 2.14 % | $ 2.09 B | ||
|
Harrow Health
HROW
|
18.3 | $ 37.1 | 3.26 % | $ 1.36 B | ||
|
Aurora Cannabis
ACB
|
1.45 K | $ 3.48 | 1.46 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
177 | $ 1.08 | 2.86 % | $ 116 M | ||
|
OrganiGram Holdings
OGI
|
2.92 K | $ 1.42 | 1.43 % | $ 402 M | ||
|
Jupiter Wellness
JUPW
|
-206 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
173 | - | 1.15 % | $ 7.11 M | ||
|
Evolus
EOLS
|
74.8 | $ 4.33 | 1.41 % | $ 279 M | ||
|
Emergent BioSolutions
EBS
|
181 | $ 8.24 | 3.52 % | $ 422 M | ||
|
Tilray
TLRY
|
169 | $ 6.72 | 2.28 % | $ 4.15 B | ||
|
Organogenesis Holdings
ORGO
|
64.5 | $ 2.38 | - | $ 313 M | ||
|
Pacira BioSciences
PCRX
|
209 | $ 24.06 | 1.13 % | $ 1.11 B | ||
|
PetIQ
PETQ
|
53.8 | - | 1.64 % | $ 400 M | ||
|
Veru
VERU
|
6.7 | $ 2.38 | - | $ 321 M | ||
|
Viatris
VTRS
|
155 | $ 13.83 | 2.67 % | $ 16.6 B | ||
|
ProPhase Labs
PRPH
|
96 | - | - | $ 5.07 M | ||
|
cbdMD
YCBD
|
92 | $ 0.75 | 9.54 % | $ 3.23 M | ||
|
Assertio Holdings
ASRT
|
467 | $ 18.02 | - | $ 115 M | ||
|
Radius Health
RDUS
|
-53.5 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
105 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
314 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
106 | $ 1.01 | 1.0 % | $ 50.4 M | ||
|
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
150 | $ 2.35 | 3.07 % | $ 2.92 M | ||
|
Zomedica Corp.
ZOM
|
154 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
57 | $ 0.94 | 3.31 % | $ 33.8 M | ||
|
China Pharma Holdings
CPHI
|
139 | $ 0.65 | 0.6 % | $ 2.79 M | ||
|
TherapeuticsMD
TXMD
|
-723 | $ 2.05 | -0.97 % | $ 23.7 M |